Agilent Technologies (NYSE:A) Stock Price Expected to Rise, TD Cowen Analyst Says

Agilent Technologies (NYSE:A) had its target price boosted by stock analysts at TD Cowen from $180.00 to $196.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. TD Cowen’s price target indicates a potential upside of 14.79% from the company’s previous close.

A has been the topic of a number of other research reports. UBS Group assumed coverage on shares of Agilent Technologies in a research report on Wednesday, September 9th. They set a “neutral” rating and a $165.00 price objective on the stock. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday. Morgan Stanley increased their price target on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Wall Street Zen downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, October 3rd. Finally, Bank of America lifted their price objective on Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $173.65.

Agilent Technologies Stock Performance

Shares of NYSE:A traded down $0.58 during midday trading on Tuesday, reaching $170.75. 341,925 shares of the company’s stock traded hands, compared to its average volume of 2,260,540. The company has a market cap of $48.14 billion, a price-to-earnings ratio of 33.60, a P/E/G ratio of 2.60 and a beta of 1.21. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies has a one year low of $108.35 and a one year high of $177.05. The stock has a 50 day moving average of $156.48 and a 200 day moving average of $136.00.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same period last year, the firm posted $1.37 earnings per share. Agilent Technologies’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities research analysts anticipate that Agilent Technologies will post 6.20 EPS for the current fiscal year.

Insider Activity

In related news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Institutional Investors Weigh In On Agilent Technologies

Hedge funds and other institutional investors have recently modified their holdings of the stock. SHP Wealth Management purchased a new stake in Agilent Technologies in the fourth quarter worth about $26,000. Markowski Investments bought a new position in shares of Agilent Technologies during the 2nd quarter valued at approximately $27,000. MV Capital Management Inc. bought a new position in shares of Agilent Technologies during the 4th quarter valued at approximately $28,000. Cedar Mountain Advisors LLC purchased a new stake in Agilent Technologies in the 1st quarter worth approximately $27,000. Finally, Keating Financial Advisory Services Inc. purchased a new stake in Agilent Technologies in the 2nd quarter worth approximately $31,000.

About Agilent Technologies

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.

The company’s products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.